Biologics Safety Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Biosafety Testing Companies and the market is segmented by Product (Reagents and Kits, Instruments and Other Products), by Application (Vaccines and Therapeutics, Cellular and Gene Therapy, Blood and Blood-based Therapy and Other Applications), by Test (Sterility Tests, Bioburden Tests, Endotoxin Tests, Other Tests), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market provides the value (in USD million) for the above-mentioned segments.

Biologics Safety Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Biological Safety Testing Industry Overview

The biological safety testing market is highly competitive and consists of a few major players. Companies, like Avance Biosciences, Cytovance Biologics, Eurofins Scientific, Lonza, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Toxikon, and WuXi AppTec, among others, hold a substantial share in the market.

Biological Safety Testing Market Leaders

  1. Eurofins Scientific

  2. Lonza

  3. Merck KGaA

  4. Promega Corporation

  5. Thermo Fisher Scientific

  6. *Disclaimer: Major Players sorted in no particular order
Biological Safety Testing Market.png

Biologics Safety Testing Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?